A phase I/ II trial of pazopanib (Paz) alternating (alt) with bevacizumab (Bev) in treatment-naive metastatic clear cell renal cell carcinoma (mccRCC) patients (pts): Phase II results

被引：0
|
作者：
George, S. [1 ]
Vaishampayan, U. N. [2 ]
Hutson, A. [3 ]
Groman, A. [3 ]
Roche, C. L. [4 ]
Herbst, L. [5 ]
Kallicharsn-Smith, R. [6 ]
DiRaddo, A-M. [6 ]
Farrell, E. [6 ]
Kilari, D. [7 ,8 ]
Gopalakrishnan, D. [5 ]
Heath, E. [9 ]
Wulff-Burchfield, E. [10 ]
Appleman, L. J. [11 ]
Parikh, R. [12 ]
机构：
[1] Roswell Park Comprehens Canc Ctr, Med Dept, Orchard Pk, NY USA
[2] Univ Michigan, Michigan Med, Div Hematol Oncol, Ann Arbor, MI 48109 USA
[3] Roswell Park Comprehens Canc Ctr, Biostat, Buffalo, NY USA
[4] Roswell Park Comprehens Canc Ctr, Radiol, Buffalo, NY USA
[5] Roswell Park Comprehens Canc Ctr, Med Dept, Buffalo, NY USA
[6] Roswell Park Comprehens Canc Ctr, Clin Res, Buffalo, NY USA
[7] Froedtert Hosp, Med Dept, Milwaukee, WI USA
[8] Med Coll Wisconsin, Milwaukee, WI 53226 USA
[9] Karmanos Canc Inst, Oncol, Detroit, MI USA
[10] KUMC Univ Kansas, Med Ctr, Internal Med, Kansas City, KS USA
[11] Univ Pittsburgh, Canc Inst, Med, Pittsburgh, PA USA
[12] KUMC Univ Kansas, Med Ctr, Med Dept, Kansas City, KS USA
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.08.1789
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1696P
引用
收藏
页码：S1016 / S1017
页数：2
相关论文
共 50 条
  • [1] A phase I/II trial of pazopanib alternating with bevacizumab in treatment-naive metastatic clear cell renal cell carcinoma (CCRCC) patients: Phase I results.
    George, Saby
    Herbst, Laurie
    Sikorski, Marcus
    Diraddo, Ann Marie
    Azabdaftari, Gissou
    Roche, Charles
    Kauffman, Eric
    Li, Qiang
    Schwaab, Thomas
    Levine, Ellis Glenn
    Pili, Roberto
    Chatta, Gurkamal S.
    Appleman, Leonard Joseph
    Groman, Adrienne
    Parikh, Rahul Atul
    Hutson, Alan
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (07)
  • [2] Presurgical bevacizumab in patients with metastatic clear cell renal cell carcinoma: A phase II study
    Jonasch, E.
    Wood, C. G.
    Matin, S.
    Tamboli, P.
    Do, K.
    Pagliaro, L. C.
    Aparicio, A. M.
    Araujo, J. C.
    Tannir, N. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [3] Phase II efficacy trial of pazopanib in non-clear cell metastatic renal cell carcinoma (PINCR trial).
    Costello, Brian Addis
    Thai Huu Ho
    Tan, Winston
    Leibovich, Bradley C.
    Castle, Erik P.
    Parker, Alexander S.
    Dronca, Roxana Stefania
    Qin, Rui
    Kohll, Manish
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [4] A phase II study of the efficacy and safety of sunitinib in treatment-naive and pretreated Japanese patients (pts) with metastatic renal cell carcinoma (mRCC)
    Uemura, H.
    Shinohara, N.
    Naito, S.
    Akaza, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [5] A phase I/II trial of sorafenib (S) with bevacizumab (B) in metastatic renal cell cancer (mRCC) patients (Pts).
    Sosman, J. A.
    Flaherty, K.
    Atkins, M. B.
    Puzanov, I.
    McDermott, D. F.
    Vermeulen, W.
    Harlacker, K.
    Hsu, A.
    Rothenberg, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 128S - 128S
  • [6] Phase I trial of bevacizumab plus sunitinib in patients (pts) with metastatic renal cell carcinoma (mRCC)
    Feldman, D. R.
    Kondagunta, G. V.
    Ronnen, E. A.
    Fischer, P.
    Chang, R.
    Baum, M.
    Ginsberg, M. S.
    Ishill, N.
    Patil, S.
    Motzer, R. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [7] A Phase I/II study to assess the safety and efficacy of pazopanib (paz) and pembrolizumab (pembro) in patients (pts) with advanced renal cell carcinoma (aRCC)
    McDermott, D. F.
    Infante, J. R.
    Chowdhury, S.
    Voss, M. H.
    Motzer, R. J.
    Perini, R. F.
    Morosky, A.
    Zheng, F. F.
    White, B. C.
    Wang, Q.
    Jewell, R. C.
    Rini, B. I.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S519 - S520
  • [8] Phase II trial of sunitinib in patients with metastatic non-clear cell renal cell carcinoma
    Ana M. Molina
    Darren R. Feldman
    Michelle S. Ginsberg
    Glenn Kroog
    Satish K. Tickoo
    Xiaoyu Jia
    Murielle Georges
    Sujata Patil
    Michael S. Baum
    Victor E. Reuter
    Robert J. Motzer
    Investigational New Drugs, 2012, 30 : 335 - 340
  • [9] Phase II trial of sunitinib in patients with metastatic non-clear cell renal cell carcinoma
    Molina, Ana M.
    Feldman, Darren R.
    Ginsberg, Michelle S.
    Kroog, Glenn
    Tickoo, Satish K.
    Jia, Xiaoyu
    Georges, Murielle
    Patil, Sujata
    Baum, Michael S.
    Reuter, Victor E.
    Motzer, Robert J.
    INVESTIGATIONAL NEW DRUGS, 2012, 30 (01) : 335 - 340
  • [10] A phase I/II study to assess the safety and efficacy of pazopanib (PAZ) and pembrolizumab (PEM) in patients (pts) with advanced renal cell carcinoma (aRCC).
    Chowdhury, Simon
    McDermott, David F.
    Voss, Martin Henner
    Hawkins, Robert E.
    Aimone, Paola
    Voi, Maurizio
    Isabelle, Naeije
    Wu, Vi
    Infante, Jeffrey R.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
12345